Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06274268

Effect of Sarcopenia on the Occurrence of Toxicity Related to Anti-cancer Treatments

Led by Centre Hospitalier Metropole Savoie · Updated on 2024-07-18

700

Participants Needed

1

Research Sites

201 weeks

Total Duration

On this page

Sponsors

C

Centre Hospitalier Metropole Savoie

Lead Sponsor

U

Université Savoie Mont Blanc

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this clinical trial is to learn about the effect of sarcopenic status on the occurrence of treatment-related toxicity during the first course of anti-cancer treatment in several types of cancers. The main question it aims to answer is : Is sarcopenia a predictive marker for the occurrence of toxicity in the initial phase of cancer treatment? The evaluation will focus on the body composition of the participants, assessed by impedancemetry, and on their muscular performance by standardized physical tests.

CONDITIONS

Official Title

Effect of Sarcopenia on the Occurrence of Toxicity Related to Anti-cancer Treatments

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients over 18 years old
  • Diagnosis of a histologically proven solid malignant tumor with an indication for first-line systemic treatment
  • CT or PET scan performed within 45 days before starting systemic treatment
  • Able to sign informed consent for study participation
  • Affiliated to a social security system
Not Eligible

You will not qualify if you...

  • History of cancer in the past 5 years except localized skin or cervical cancer
  • Cancer not requiring systemic treatment
  • Pregnant women
  • Presence of a pacemaker or defibrillator
  • Patient deprived of liberty or under legal protection measures

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Centre Hospitalier Metropole Savoie

Chambéry, France, 73000

Actively Recruiting

Loading map...

Research Team

A

Aurelie FILLON

CONTACT

N

Nathalie MARQUES, Dr

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here